Does the addition of divalproex sodium [valproate semisodium] ER [extended release] to an atypical antipsychotic drug improve cognition and psychopathology in outpatients with schizophrenia (SCH) or schizoaffective disorder (SAD)?
Phase of Trial: Phase IV
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Antipsychotics; Valproate semisodium
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 25 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2006 New trial record.